Skip to main content
RXST
NASDAQ Life Sciences

Q3 Revenue Falls 19% to $24.6M as Net Loss Widens to $16.2M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.59
Mkt Cap
$190.913M
52W Low
$4.4
52W High
$13.22
52W Position info
4.3% above low
Off High info
65% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

RXST is trading near its 52-week low of $4.4 (4.3% above the low).

Summary

RxSight's Q3 revenue fell 19% to $24.6 million on 23,128 LAL units as competitive pressure persists, and the net loss widened to $16.2 million, or $0.39 a share, from $9.8 million a year ago. Gross margin dropped to 73.6% from 79.9% on higher inventory reserves and LAL/LDD costs. The Alcon collaboration contributed only $40 thousand of revenue in the quarter, so the partnership has not yet offset the core decline. Cash and short-term investments of $254.7 million include the $60 million Alcon payment, but the balance sheet also carries a $50 million refund liability. Management is betting on a nearly doubled sales force, new commercial leadership and a completed restructuring to stabilize the business; with the stock near its 52-week low, execution on those cost savings and any Alcon revenue ramp are the swing factors.

At the time of this announcement, RXST was trading at $4.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $190.9M. The 52-week trading range was $4.40 to $13.22. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

RXST - Latest Insights

RXST
Nov 03, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.92
Real-time Price: $4.91 info
Change: +$0.985 (+25%) info
Market Cap: $205.663M info
RXST
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.59
Real-time Price: $4.91 info
Change: +$0.315 (+7%) info
Market Cap: $205.663M info
RXST
Aug 10, 2026, 8:01 AM EDT
Filing Type: SC TO-I
Importance Score:
7
Price at Filing: $6.26
Real-time Price: $4.91 info
Change: -$1.35 (-22%) info
Market Cap: $205.663M info
RXST
Jul 15, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.25
Real-time Price: $4.91 info
Change: -$0.345 (-7%) info
Market Cap: $205.663M info
RXST
Jul 06, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.54
Real-time Price: $4.91 info
Change: -$0.635 (-11%) info
Market Cap: $205.663M info